Tempus AI Cancer Genomics

Tempus AI Cancer Genomics transforms oncology with the world's largest library of clinical and molecular data, spanning 7 million+ patient records integrated with genomic sequencing to train AI models. These models match cancer patients to clinical trials, predict treatment response, and identify novel biomarkers, with its TIME trial matching platform connecting 1 in 5 eligible patients — far exceeding the typical 3% enrollment rate. Compared to AI-Powered Surgical Robots, this tackles a broader systemic challenge, as 85% of trials fail due to insufficient enrollment, making Tempus 30% more effective at addressing trial recruitment than the average alternative.